Notices. Notice
405 words·~2 min read·
/register/2017/07/03/2017-13890A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2016-N-2976; FDA-2016-N-3535; FDA-2013-N-1089; FDA-2013-N-1619; FDA-2013-N-0719; FDA-2016-N-3586; FDA-2013-N-0796; FDA-2016-N-0736; FDA-2016-N-3995; FDA-2013-D-0575; FDA-2016-N-0735] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A63, 11601 Landsdown St., North Bethesda, MD 20852,
(301)796-7726, *PRAStaff@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the Internet at *https://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved by OMB Title of collection OMB control No. Date approval expires Request for Information From U.S. Processors That Export to the European Community 0910-0320 5/31/2020 Guidance for Industry: Special Protocol Assessment 0910-0470 5/31/2020 Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use 0910-0553 5/31/2020 Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements 0910-0606 5/31/2020 Guidance for Industry: Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products 0910-0675 5/31/2020 Focus Groups About Drug Products as Used by the Food and Drug Administration 0910-0677 5/31/2020 Testing Communication on Medical Devices and Radiation-Emitting Products 0910-0678 5/31/2020 Tracking Network for PETNet, LivestockNet, and SampleNet 0910-0680 5/31/2020 Medical Devices: Pediatric Uses of Devices; Requirements for Submission of Information on Pediatric Subpopulations That Suffer From a Disease or Condition That a Device is Intended to Treat, Diagnose, or Cure 0910-0748 5/31/2020 Guidance for Industry: Expedited Programs for Serious Conditions—Drugs and Biologics 0910-0765 5/31/2020 Superimposed Text in Direct-to-Consumer Promotion of Prescription Drugs 0910-0831 5/31/2020 Dated: June 27, 2017. Anna K. Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis. [FR Doc. 2017-13890 Filed 6-30-17; 8:45 am]
Connectionstraces to 1
Traces to 1 document